featured
Tipifarnib in Recurrent Metastatic HRAS-Mutant Salivary Gland Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tipifarnib in Recurrent, Metastatic HRAS-Mutant Salivary Gland Cancer
Cancer 2020 Jun 18;[EPub Ahead of Print], GJ Hanna, JP Guenette, NG Chau, CM Sayehli, C Wilhelm, R Metcalf, DJ Wong, M Brose, M Razaq, E Pérez-Ruiz, EEW Cohen, R Aggarwal, C Scholz, A Gualberto, AL HoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.